A row has broken out over intellectual property rights and the funding model of Europe’s €2B flagship research programme, the Innovative Medicines Joint Technology Initiative.
The EU may divert €460 million from the Seventh Framework Programme to fund the International Thermonuclear Experimental Reactor (ITER) nuclear fusion project.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.